Table:
begin	end	state
1	12	non-cytoplasmic
13	32	transmembrane
33	60	cytoplasmic
61	86	transmembrane
87	91	non-cytoplasmic
92	112	transmembrane
113	142	cytoplasmic
143	165	transmembrane
166	175	non-cytoplasmic
176	196	transmembrane
197	207	cytoplasmic
208	229	transmembrane
230	234	non-cytoplasmic
235	259	transmembrane
260	295	cytoplasmic
296	318	transmembrane
319	347	non-cytoplasmic
348	368	transmembrane
369	379	cytoplasmic
380	400	transmembrane
401	405	non-cytoplasmic
406	429	transmembrane
430	492	cytoplasmic

Input:
>WP_086509070.1 NCBI__GCF_002151265.1:WP_086509070.1
MLDLINDLLWGKVLIALLIAVGVGFTLSSRFVQFRYFARMFRILGASQAFKRDKHGHLSS
FQALLLSIAGRVGGGNIAGVAVAITLGGPGAIFWMWLVGLMGMATSFLECTLAQAYKTAQ
PDGTYRGGPAYYIARGLGSRWKWLAALYSVLLLVTFGFGFTALQSYAVATSFDDAFGIPV
LYTGIGMAAVVGLIIFGGIKRIARVTEVLVPVMAVGYLLIAFVVLGMNLPRIPEVFLLIV
NSAFGLEPAVGGGIGAAIMMGVKRGLFSNEAGLGSAPNVAAVAYVPHPANQGVVQAFSVF
IDTLIICSATAFIILLSGAYDPASGADIGGVALTQVSLADHVGEWGRSFVSVALLLFGFS
TILYNYYLGENSLNYFSDGNVTLFNLFRIAIVALCAWGALTDLGTVFAFADVTMGFLALA
NLIALLMLFKPGLRLMRDFDEQIRAGIRHPVFDAQKFADLDIDPAAWEIEPEDIERLKRY
GAAAPTAGQPAK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server